|
Conference on Intellectual
Property and International Public Health
“Balancing Economics and Social Responsibility”
The Leavey Center, Georgetown University
Washington, DC
October 6-8, 2003
|
Presented by
The International Intellectual Property Institute
and co-sponsored by
The Georgetown University McDonough School of Business,
The World Intellectual Property Organization and
The United States Patent and Trademark Office
|
Exploring the relationships between patents, pharmaceutical
innovation and public health
Untangling complex relationships that drive the development, pricing
and accessibility of new drugs is key to advancing public health
systems in both industrialized and developing countries. How can
profit-making pharmaceutical companies recoup development costs,
generate profits and act with social responsibility?
Limited to approximately 200 participants, Intellectual Property and
International Public Health offers a select group of healthcare
professionals from around the world a unique opportunity to speak
candidly about today’s most pressing issues. This conference
promises to shed new light on several vital issues dominating the
international public health stage.
At this conference, participants will:
-
Explore the relationship of the
patent system to new drug development
-
Examine how patents impact the
pricing of drugs
-
Evaluate the differences in the
markets for patented drugs among developed countries
-
Learn about the relationship of
publicly funded research to new drug development
-
Consider possible solutions to the
problem of providing patented drugs to patients in poor countries
-
Explore the role of patents in
research directed at medicines needed in developing countries
|
Hear Health Ministers from
countries such as Jordan, Mexico, Uganda and the Czech Republic
express global views on balancing intellectual property requirements
with public health needs and financial constraints.
Select conference topics include:
-
Exploring patents and innovation
through public/private partnerships
-
Bringing new medicines to the
marketplace: regulatory and financial issues
-
Examining the generic industry and
its role and co-existence with the patented pharmaceutical industry
-
Discussing the impact of regulatory
and pricing policies in developed countries on global innovation and
investment in patent-based research
-
Finding socially responsible
strategies for improving the public health infrastructure in
developing countries
-
Debating national versus
international exhaustion of rights and tiered pricing of patented
pharmaceuticals.
|
|
|
